SPY
769.86
+0.03%
QQQ
749.55
−0.00%
BTC/USD
86,327.53
−0.22%
DIA
511.70
+0.12%
GLD
380.52
+0.10%
TLT
77.53
+0.06%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Incyte Corp
INCY
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$115.30
-1.84
-1.57%
Last update: Oct 2, 4:12 PM
$115.30
-1.84
-1.57%
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Incyte Financials
Incyte (INCY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results
Incyte Corp. (INCY) reported strong Q2 results, raised full-year sales guidance. CEO cites sales growth, pipeline progress, and business development. Analysts maintain buy ratings with price target increases.
Avi Kapoor
Incyte Says It's No Longer A One-Drug Story
Incyte (INCY) Q2 earnings beat estimates with $1.67B revenue, $3.09 EPS. Full-year sales guidance raised. Shares rally to new 52-week high.
Vandana Singh
PRO
Incyte Q2 Adj. EPS $3.09 Beats $2.12 Estimate, Sales $1.663B Beat $1.460B Estimate
Incyte (NASDAQ:INCY) reported quarterly earnings of $3.09 per share which beat the analyst consensus estimate of $2.12 by 45.75 percent. This is a 96.82 percent increase over earnings of $1.57 per share from the same
Benzinga Newsdesk
PRO
Incyte Raises FY2026 Sales Guidance from $4.770B-$4.940B to $5.130B-$5.260B vs $5.712B Est
Incyte (NASDAQ:INCY) raises FY2026 sales outlook from $4.770 billion-$4.940 billion to $5.130 billion-$5.260 billion vs $5.712 billion estimate.
Benzinga Newsdesk
PRO
Incyte Sees FY2026 Sales $4.770B-$4.940B vs $5.569B Est
Incyte (NASDAQ:INCY) sees FY2026 sales of $4.770 billion-$4.940 billion vs $5.569 billion analyst estimate.
Benzinga Newsdesk
PRO
CORRECTION: Incyte Q1 Adj. EPS $1.81 Beats $1.37 Estimate, Sales $1.273B Beat $1.217B Estimate.
Incyte (NASDAQ:INCY) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.37 by 32.12 percent. This is a 56.03 percent increase over earnings of $1.16 per share from the same
Benzinga Newsdesk
